FSPKF (Fisher & Paykel Healthcare) Interest Expense: $-6 Mil (TTM As of Mar. 2026)


FSPKF Fisher & Paykel Healthcare Corp Ltd FSPKF
90 GF Score
Price $22.52
GF Value $25.98
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Fisher & Paykel Healthcare Interest Expense?

Fisher & Paykel Healthcare FSPKF +9.59% 90 Interest Expense is $-6 Mil as of Mar. 2026. GuruFocus rates FSPKF with a GF Score™ of 90/100 and a GF Value™ of $25.98 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Fisher & Paykel Healthcare's interest expense for the six months ended in Mar. 2026 was $ -3 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was $-6 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Fisher & Paykel Healthcare's Operating Income for the six months ended in Mar. 2026 was $ 149 Mil. Fisher & Paykel Healthcare's Interest Expense for the six months ended in Mar. 2026 was $ -3 Mil. Fisher & Paykel Healthcare's Interest Coverage for the quarter that ended in Mar. 2026 was 53.02. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Fisher & Paykel Healthcare  (OTCPK:FSPKF) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Fisher & Paykel Healthcare's Interest Expense for the six months ended in Mar. 2026 was $-3 Mil. Its Operating Income for the six months ended in Mar. 2026 was $149 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Mar. 2026 was $66 Mil.

Fisher & Paykel Healthcare's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Interest Coverage=-1* Operating Income (Q: Mar. 2026 )/Interest Expense (Q: Mar. 2026 )
=-1*148.83/-2.807
=53.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Fisher & Paykel Healthcare Interest Expense Historical Data

* Premium members only.

The historical data trend for Fisher & Paykel Healthcare's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fisher & Paykel Healthcare Interest Expense Chart

Fisher & Paykel Healthcare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.37 -4.16 -11.07 -6.36 -6.02

Fisher & Paykel Healthcare Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.78 -3.05 -3.55 -3.24 -2.81
FSPKF
90GF Score
Fisher & Paykel Healthcare Corp Ltd FSPKF
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fisher & Paykel Healthcare Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $-6 Mil mean?
Fisher & Paykel Healthcare (FSPKF) has a Interest Expense of $-6 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Fisher & Paykel Healthcare and its competitors.
Is Fisher & Paykel Healthcare's Interest Expense too high?
Fisher & Paykel Healthcare's current Interest Expense is $-6 Mil. Overall, Fisher & Paykel Healthcare has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Fisher & Paykel Healthcare's Interest Expense compare to ISRG and BDX?
Fisher & Paykel Healthcare's Interest Expense of $-6 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Medical Devices & Instruments company?
A good Interest Expense depends on the Medical Devices & Instruments industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Fisher & Paykel Healthcare and its competitors. Fisher & Paykel Healthcare's current Interest Expense is $-6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fisher & Paykel Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Fisher & Paykel Healthcare (FSPKF) is currently considered Modestly Undervalued. The stock's GF Value™ is $25.98, compared to a current price of $22.52 — trading 13.3% below its estimated fair value. The current Interest Expense is $-6 Mil. Fisher & Paykel Healthcare's overall GF Score™ is 90/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Fisher & Paykel Healthcare (FSPKF), the current Interest Expense is $-6 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fisher & Paykel Healthcare (FSPKF) Overvalued in 2026?

Based on GuruFocus' analysis, Fisher & Paykel Healthcare stock appears to be undervalued. The current stock price of $22.52 is trading 13.3% below its estimated GF Value™ of $25.98. GuruFocus considers Fisher & Paykel Healthcare to be Modestly Undervalued.

Key valuation signals for FSPKF:

  • Interest Expense: $-6 Mil
  • GF Value™: $25.98 vs. price of $22.52 (13.3% below fair value)
  • GF Score™: 90/100 with 2 warning signs

No single metric tells the full story. See the FSPKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fisher & Paykel Healthcare Business Description

Address 15 Maurice Paykel Place, East Tamaki, Auckland, NTL, NZL, 2013
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use of humidifiers, masks, and related consumables, and the number three player in the at-home treatment of sleep apnea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns roughly half of its revenue in North America, around a quarter in Europe, and approximately a fifth in Asia-Pacific. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand, Mexico, and China, and has a multichannel distribution model.
90GF Score

Get the complete analysis for FSPKF

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$22.52
Price
$25.98
GF Value